CREBBP c.1384A>G ;(p.T462A)

Variant ID: 16-3832874-T-C

NM_004380.2(CREBBP):c.1384A>G;(p.T462A)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


BET proteolysis targeted chimera-based therapy of novel models of Richter Transformation-diffuse large B-cell lymphoma.

Leukemia
Fiskus, Warren W; Mill, Christopher P CP; Perera, Dimuthu D; Birdwell, Christine C; Deng, Qing Q; Yang, Haopeng H; Lara, Bernardo H BH; Jain, Nitin N; Burger, Jan J; Ferrajoli, Alessandra A; Davis, John A JA; Saenz, Dyana T DT; Jin, Wendy W; Coarfa, Cristian C; Crews, Craig M CM; Green, Michael R MR; Khoury, Joseph D JD; Bhalla, Kapil N KN
Publication Date: 2021-09

Variant appearance in text: CREBBP: T462A
PubMed Link: 33654205
Variant Present in the following documents:
  • 41375_2021_1181_MOESM1_ESM.pdf
View BVdb publication page



Genetic modification of primary human B cells to model high-grade lymphoma.

Nature Communications
Caeser, Rebecca R; Di Re, Miriam M; Krupka, Joanna A JA; Gao, Jie J; Lara-Chica, Maribel M; Dias, João M L JML; Cooke, Susanna L SL; Fenner, Rachel R; Usheva, Zelvera Z; Runge, Hendrik F P HFP; Beer, Philip A PA; Eldaly, Hesham H; Pak, Hyo-Kyung HK; Park, Chan-Sik CS; Vassiliou, George S GS; Huntly, Brian J P BJP; Mupo, Annalisa A; Bashford-Rogers, Rachael J M RJM; Hodson, Daniel J DJ
Publication Date: 2019-10-04

Variant appearance in text: CREBBP: Thr462Ala
PubMed Link: 31586074
Variant Present in the following documents:
  • 41467_2019_12494_MOESM6_ESM.xlsx, sheet 1
View BVdb publication page